Bruce D Gaynor

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc The easiest children to reach are most likely to be infected with ocular Chlamydia trachomatis in trachoma endemic areas of Niger
    Abdou Amza
    Programme National de Lutte Contre la Cecité, Niamey, Niger
    PLoS Negl Trop Dis 7:e1983. 2013
  2. pmc Community risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trial
    Abdou Amza
    Programme National de Lutte Contre la Cecité, Niamey, Niger
    PLoS Negl Trop Dis 6:e1586. 2012
  3. doi Travel and implications for the elimination of trachoma in ethiopia
    Neelima A Shah
    Department of Public Health Sciences, University of California, Davis, California, USA
    Ophthalmic Epidemiol 17:113-7. 2010
  4. pmc A rationale for continuing mass antibiotic distributions for trachoma
    Kathryn J Ray
    Francis I, Proctor Foundation, University of California, San Francisco, CA, USA
    BMC Infect Dis 7:91. 2007
  5. ncbi Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma
    Jaya D Chidambaram
    F I Proctor Foundation, University of California, San Francisco, CA 94143 0412, USA
    JAMA 295:1142-6. 2006
  6. pmc Diagnostic characteristics of tests for ocular Chlamydia after mass azithromycin distributions
    Jeremy D Keenan
    F I Proctor Foundation, 513 Parnassus Avenue, Med Sci S309, Box 0412, University of California, San Francisco, San Francisco, CA 94143 0412, USA
    Invest Ophthalmol Vis Sci 53:235-40. 2012
  7. pmc Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma
    Jeremy D Keenan
    FI Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, CA 94143 0412, USA
    Clin Infect Dis 54:253-6. 2012
  8. pmc Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma
    Jeremy D Keenan
    Department of Ophthalmology, University of California, San Francisco, CA, USA
    Am J Trop Med Hyg 82:482-7. 2010
  9. doi Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions
    Jesse B Biebesheimer
    FI Proctor Foundation, University of California, San Francisco, California 94143 0412, USA
    Ophthalmology 116:2047-50. 2009
  10. pmc A cluster-randomized controlled trial evaluating the effects of mass azithromycin treatment on growth and nutrition in Niger
    Abdou Amza
    Université Abdou Moumouni de Niamey, Programme National de Lutte Contre la Cecité, Niamey, Niger
    Am J Trop Med Hyg 88:138-43. 2013

Collaborators

Detail Information

Publications19

  1. pmc The easiest children to reach are most likely to be infected with ocular Chlamydia trachomatis in trachoma endemic areas of Niger
    Abdou Amza
    Programme National de Lutte Contre la Cecité, Niamey, Niger
    PLoS Negl Trop Dis 7:e1983. 2013
    ....
  2. pmc Community risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trial
    Abdou Amza
    Programme National de Lutte Contre la Cecité, Niamey, Niger
    PLoS Negl Trop Dis 6:e1586. 2012
    ..But it remains unclear what the community-level risk factors are for infection...
  3. doi Travel and implications for the elimination of trachoma in ethiopia
    Neelima A Shah
    Department of Public Health Sciences, University of California, Davis, California, USA
    Ophthalmic Epidemiol 17:113-7. 2010
    ..Seven hundred and seventeen households with at least one child aged 1-5 years in 48 villages were surveyed to collect the details of travel in 1 month prior to the survey...
  4. pmc A rationale for continuing mass antibiotic distributions for trachoma
    Kathryn J Ray
    Francis I, Proctor Foundation, University of California, San Francisco, CA, USA
    BMC Infect Dis 7:91. 2007
    ..Here we use mathematical models to demonstrate that repeated antibiotic distributions can eliminate infection in a reasonable time period...
  5. ncbi Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma
    Jaya D Chidambaram
    F I Proctor Foundation, University of California, San Francisco, CA 94143 0412, USA
    JAMA 295:1142-6. 2006
    ..Some hypothesize that a single distribution is sufficient to control the ocular strains of chlamydia that cause trachoma. Others believe infection will inevitably return and periodic treatments or other measures are essential...
  6. pmc Diagnostic characteristics of tests for ocular Chlamydia after mass azithromycin distributions
    Jeremy D Keenan
    F I Proctor Foundation, 513 Parnassus Avenue, Med Sci S309, Box 0412, University of California, San Francisco, San Francisco, CA 94143 0412, USA
    Invest Ophthalmol Vis Sci 53:235-40. 2012
    ....
  7. pmc Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma
    Jeremy D Keenan
    FI Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, CA 94143 0412, USA
    Clin Infect Dis 54:253-6. 2012
    ..An RNA-based test detected ocular chlamydial infection in more children than did a DNA-based test (6.9% vs 4.2%), and in a larger number of communities (8 vs 7)...
  8. pmc Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma
    Jeremy D Keenan
    Department of Ophthalmology, University of California, San Francisco, CA, USA
    Am J Trop Med Hyg 82:482-7. 2010
    ....
  9. doi Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions
    Jesse B Biebesheimer
    FI Proctor Foundation, University of California, San Francisco, California 94143 0412, USA
    Ophthalmology 116:2047-50. 2009
    ..To determine whether infectious trachoma can be completely eliminated from severely affected villages...
  10. pmc A cluster-randomized controlled trial evaluating the effects of mass azithromycin treatment on growth and nutrition in Niger
    Abdou Amza
    Université Abdou Moumouni de Niamey, Programme National de Lutte Contre la Cecité, Niamey, Niger
    Am J Trop Med Hyg 88:138-43. 2013
    ..There may not be an association between antibiotic use and improved growth in humans, or this trial was not powerful enough to detect an association if it exists...
  11. doi Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial
    Jenafir I House
    FI Proctor Foundation, University of California, San Francisco, USA
    Lancet 373:1111-8. 2009
    ..We assessed indirect protection against trachoma with mass azithromycin distributions...
  12. pmc The association between latrine use and trachoma: a secondary cohort analysis from a randomized clinical trial
    Meron Haile
    Francis I Proctor Foundation, University of California, San Francisco, California The Carter Center, Addis Ababa, Ethiopia Departments of Ophthalmology and Epidemiology and Biostatistics, University of California, San Francisco, California The Carter Center, Atlanta, Georgia Institute for Global Health, University of California, San Francisco, California
    Am J Trop Med Hyg 89:717-20. 2013
    ..Specifically, for each 10% increase in latrine use, there was a 2.0% decrease (95% confidence interval = 0.2-3.9% decrease) in the community prevalence of ocular chlamydia over the subsequent year (P = 0.04)...
  13. ncbi Mass antibiotic treatment and community protection in trachoma control programs
    Jaya D Chidambaram
    F I Proctor Foundation for Research in Ophthalmology, University of California, San Francisco, CA 94143 0944, USA
    Clin Infect Dis 39:e95-7. 2004
    ..Similarities with the indirect protection within a treated community (i.e., "herd protection") that has been observed in vaccination programs are discussed...
  14. doi The decline of pneumococcal resistance after cessation of mass antibiotic distributions for trachoma
    Sara Haug
    FI Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, California 94143 0944, USA
    Clin Infect Dis 51:571-4. 2010
    ..6% (95% CI, 18.8%-40.4%; P <.001 ) and 20.8% (95% CI, 12.7%-30.7%; P < .001), respectively. Macrolide resistance decreases after antibiotic pressure is removed...
  15. pmc Elimination and eradication of neglected tropical diseases with mass drug administrations: a survey of experts
    Jeremy D Keenan
    Francis I Proctor Foundation, University of California, San Francisco, San Francisco, California, United States of America Department of Ophthalmology, University of California, San Francisco, San Francisco, California, United States of America
    PLoS Negl Trop Dis 7:e2562. 2013
    ..We performed a survey of neglected tropical diseases experts to elicit their opinions on the role of mass drug administrations for the elimination of these infections...
  16. pmc Practice patterns and opinions in the treatment of acanthamoeba keratitis
    Catherine E Oldenburg
    F I Proctor Foundation, University of California, San Francisco, San Francisco, CA 94143 0944, USA
    Cornea 30:1363-8. 2011
    ..Management of acanthamoeba keratitis remains challenging for ophthalmologists. We conducted a survey of members of The Cornea Society to elicit expert opinions on the diagnosis and treatment of acanthamoeba keratitis...
  17. pmc Childhood mortality in a cohort treated with mass azithromycin for trachoma
    Jeremy D Keenan
    F I Proctor Foundation, San Francisco, CA, USA
    Clin Infect Dis 52:883-8. 2011
    ..Here, we monitor a large cohort in which almost 90% of individuals received azithromycin. We assess whether receiving treatment is associated with reduced all-cause and infectious childhood mortality...
  18. pmc Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial
    Alison H Skalet
    Francis I Proctor Foundation for Research in Opthalmology, University of California, San Francisco, San Francisco, California, United States of America
    PLoS Med 7:e1000377. 2010
    ..In this study, we used a randomized clinical trial design to assess whether macrolide resistance was higher in communities treated with mass azithromycin for trachoma, compared to untreated control communities...
  19. ncbi Rationale for mass antibiotic distribution for trachoma elimination
    Bruce D Gaynor
    Francis I Proctor Foundation, University of California, San Francisco, San Francisco, CA 94143, USA
    Int Ophthalmol Clin 42:85-92. 2002